力生制药(002393)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002393 力生制药

已收盘 04-24 15:00:00

{"stockData":{"symbol":"002393","market":"SZ","secType":"STK","nameCN":"力生制药","latestPrice":24.34,"timestamp":1713942228000,"preClose":24.33,"halted":0,"volume":1366215,"delay":0,"floatShares":182000000,"shares":184000000,"eps":3.4197,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"04-24 15:00:00","open":24.38,"high":24.48,"low":24.21,"amount":33272600,"amplitude":0.0111,"askPrice":24.34,"askSize":17,"bidPrice":24.33,"bidSize":69,"shortable":0,"etf":0,"ttmEps":3.4197,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714008600000},"adr":0,"adjPreClose":24.33,"symbolType":"stock","openAndCloseTimeList":[[1713922200000,1713929400000],[1713934800000,1713942000000]],"highLimit":26.76,"lowLimit":21.9,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":184244992,"pbRate":0.91,"roa":"--","roe":"8.04%","epsLYR":1.97,"committee":0.873518,"marketValue":4485000000,"floatMarketCap":4441000000,"peRate":7.117584,"changeRate":0.0004,"turnoverRate":0.0075,"status":0},"requestUrl":"/m/hq/s/002393","defaultTab":"news","newsList":[{"id":"2417735869","title":"力生制药(002393.SZ)：替格瑞洛原料药通过上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2417735869","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2417735869?lang=zh_cn&edition=full","pubTime":"2024-03-07 16:03","pubTimestamp":1709798580,"startTime":"0","endTime":"0","summary":"力生制药(002393.SZ)公告，近日，公司收到国家药品监督管理局颁发的关于替格瑞洛原料药《化学原料药上市申请批准通知书》，该品种通过化学原料药上市申请。据悉，替格瑞洛的适应症如下：替格瑞洛与阿司匹林(ASA)联合用药适用于预防成人患者的动脉粥样硬化血栓形成事件、急性冠状动脉综合征(ACS)、心肌梗塞(MI)病史和发生动脉粥样硬化血栓形成的高风险事件。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-07/doc-inamnsyk7897378.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-07/doc-inamnsyk7897378.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2409140077","title":"力生制药(002393.SZ)：硫酸沙丁胺醇片通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2409140077","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2409140077?lang=zh_cn&edition=full","pubTime":"2024-02-05 12:07","pubTimestamp":1707106020,"startTime":"0","endTime":"0","summary":"力生制药(002393.SZ)公告，公司收到国家药品监督管理局颁发的关于硫酸沙丁胺醇片2mg规格的《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。其适应症为：用于缓解支气管哮喘或喘息型支气管炎伴有支气管痉挛的病症。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-05/doc-inafxzvp7671228.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-05/doc-inafxzvp7671228.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2404590048","title":"力生制药靠资产处置最高预盈3.8亿 货币资金超21亿负债率仅16.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2404590048","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2404590048?lang=zh_cn&edition=full","pubTime":"2024-01-19 09:35","pubTimestamp":1705628100,"startTime":"0","endTime":"0","summary":"　　业绩短暂承压后，力生制药2023年盈利能力大幅提升。　　1月17日晚间，力生制药发布业绩预告，2023年预计实现归母净利润3.4亿元至3.8亿元，同比增长263.2%至305.9%。　　长江商报记者注意到，力生制药的负债较少，自2018年末以来，公司长期借款为零，资产负债率常年维持在20%以下，截至2023年9月末，公司的资产负债率为16.53%；与此同时，公司的货币资金呈增长趋势，截至2023年三季度末达21.25亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-01-19/doc-inaczksk0966710.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-01-19/doc-inaczksk0966710.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2404397643","title":"力生制药(002393.SZ)发预增，预计2023年度净利润3.4亿元-3.8亿元，同比大增263.2%-305.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2404397643","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2404397643?lang=zh_cn&edition=full","pubTime":"2024-01-17 19:22","pubTimestamp":1705490520,"startTime":"0","endTime":"0","summary":"力生制药(002393.SZ)发布公告，公司预计2023年度归属于上市公司股东的净利润为3.4亿元-3.8亿元，同比增长263.2%-305.9%。公司积极推动营销变革，调整产品销售结构，带动公司综合毛利率水平提升，同时强化预算管理和成本控制，压缩各项可控成本费用，公司成本费用均有一定幅度下降，扣除非经常性损益后的净利润实现较大幅度增长。此外，2023年度公司处置黄河道厂区土地，获得土地补偿款24790万元，受该因素影响，2023年度归属于上市公司股东的净利润有较大增幅。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-17/doc-inacvtrx3085442.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-17/doc-inacvtrx3085442.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2393179187","title":"力生制药(002393.SZ)：田边三菱拟作价3.68亿元出让天津田边75.35%股权 公司放弃优先购买权","url":"https://stock-news.laohu8.com/highlight/detail?id=2393179187","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2393179187?lang=zh_cn&edition=full","pubTime":"2023-12-21 16:50","pubTimestamp":1703148600,"startTime":"0","endTime":"0","summary":"力生制药(002393.SZ)公告，公司收到参股公司天津田边制药有限公司(“天津田边”)的控股股东日本田边三菱制药株式会社(“田边三菱”)发送的《联络函》，田边三菱拟以3.677亿元价格转让其持有的天津田边75.35%股权，公司放弃本次股权转让的优先购买权。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-21/doc-imzyuiex5088243.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-21/doc-imzyuiex5088243.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2389646851","title":"力生制药(002393.SZ)拟2500万元参设投资基金 以大健康领域核心进行布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2389646851","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2389646851?lang=zh_cn&edition=full","pubTime":"2023-12-08 20:34","pubTimestamp":1702038840,"startTime":"0","endTime":"0","summary":"力生制药(002393.SZ)公告，公司拟与博正资本投资有限公司、天津市津嘉产业投资运营有限公司等共同设立天津博正力生大健康私募股权投资基金(有限合伙)(暂定名)。本次交易公司及全资子公司天津力生投资管理有限公司共出资2500万元。该基金将以大健康领域核心，重点投向小分子创新药、生物药、高端制剂、高端器械、医疗服务等领域。据悉，本次投资有利于推动公司逐步实现业务结构的优化升级，增强公司的持续经营实力。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-08/doc-imzxiiin8007832.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-08/doc-imzxiiin8007832.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2382321267","title":"力生制药：盐酸普萘洛尔片通过仿制药一致性评价 有利于提升该药品市场竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2382321267","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2382321267?lang=zh_cn&edition=full","pubTime":"2023-11-09 15:27","pubTimestamp":1699514851,"startTime":"0","endTime":"0","summary":"力生制药（002393）公告称，公司近日收到国家药品监督管理局颁发的关于盐酸普萘洛尔片10mg规格的《药品补充申请批准通知书》（批件号：2023B05466），该药品通过仿制药质量和疗效一致性评价，有利于提升该药品市场竞争力。","market":"other","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/654c8af253243c0783753b3a","is_publish_highlight":false,"gpt_icon":0},{"id":"2382268549","title":"力生制药(002393.SZ)：盐酸普萘洛尔片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2382268549","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2382268549?lang=zh_cn&edition=full","pubTime":"2023-11-09 11:55","pubTimestamp":1699502100,"startTime":"0","endTime":"0","summary":"力生制药发布公告，近日，公司收到国家药品监督管理局颁发的关于盐酸普萘洛尔片10mg规格的《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。盐酸普萘洛尔片适应症：1.作为二级预防，降低心肌梗死死亡率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-09/doc-imztytuq0362170.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-09/doc-imztytuq0362170.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2379226813","title":"天津发展：力生制药前三季度归母净利约3.43亿元 同比增长204.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2379226813","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2379226813?lang=zh_cn&edition=full","pubTime":"2023-10-30 12:47","pubTimestamp":1698641220,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　天津发展（00882）公布力生制药2023年前9个月业绩，营业收入约9.12亿元，同比增长1.06%；归属于母公司所有者的净利润约3.43亿元，同比增长204.26%；基本每股收益1.86元。\n\n现在送您60元福利红包，直接提现不套路~~~快来参与活动吧！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-10-30/doc-imzsweus8838348.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-10-30/doc-imzsweus8838348.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2379339447","title":"力生制药公布三季报 前三季净利增加204.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2379339447","media":"智能小浪","top":-1,"share":"https://www.laohu8.com/m/news/2379339447?lang=zh_cn&edition=full","pubTime":"2023-10-29 16:11","pubTimestamp":1698567060,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　10月29日消息，力生制药发布三季度报告。　　公告显示，公司前三季度营业收入911,572,469.80元，同比增加1.06%，归属上市公司股东的净利润342,666,216.18元，同比增加204.26%。　　公告显示，十大流通股东中，中国银行股份有限公司－大成景恒混合型证券投资基金为新进流通股东。\n\n现在送您60元福利红包，直接提现不套路~~~快来参与活动吧！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2023-10-29/doc-imzsuhci8044369.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2023-10-29/doc-imzsuhci8044369.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-04-23","address":"天津市西青区西青经济技术开发区赛达北一道16号","stockEarnings":[{"period":"1week","weight":0.0358},{"period":"1month","weight":-0.0364},{"period":"3month","weight":0.0728},{"period":"6month","weight":-0.0008},{"period":"1year","weight":0.0838},{"period":"ytd","weight":-0.0678}],"companyName":"天津力生制药股份有限公司","boardCode":"AI0027","perCapita":"9734股","boardName":"医药制造业","registeredCapital":"18424万元","compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":-0.0085},{"period":"3month","weight":0.0713},{"period":"6month","weight":0.0113},{"period":"1year","weight":-0.0774},{"period":"ytd","weight":0.0158}],"survey":"　　天津力生制药股份有限公司主营业务为医药产品研发、生产和销售。公司主要产品有主胶囊、片剂、针剂等。","serverTime":1713943452152,"listedPrice":45,"stockholders":"18744人(较上一季度增加5.01%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"力生制药(002393)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供力生制药(002393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"力生制药,002393,力生制药股票,力生制药股票老虎,力生制药股票老虎国际,力生制药行情,力生制药股票行情,力生制药股价,力生制药股市,力生制药股票价格,力生制药股票交易,力生制药股票购买,力生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"力生制药(002393)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供力生制药(002393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}